Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

USA und Europa liefern sich Glaubenskrieg um Ebola-Therapie

wsj.de — Europa und die USA streiten sich, welche Behandlung angesichts der Ebola-Epidemie ethisch vertretbar und wirksam ist. Eine Gruppe aus europäischen Universitäten und medizinischen Verbänden plant, west-afrikanischen Ebola-Patienten experimentelle Medikamente zu verabreichen - ohne Kontrollgruppe. Die USA halten davon wenig.

Europeans’ Plan to do Uncontrolled Ebola Trial Draws Fire

online.wsj.com — Medical groups in the U.K. and France say that it would be unethical to hold back experimental Ebola treatments from anyone. U.S. officials say that without control groups getting placebos, it can't be known whether the drugs are saving lives or killing people.

Judge Slashes Damages Takeda, Lilly to Pay in Actos Case to $38.1 Million

online.wsj.com — A U.S. judge slashed the amount of damages that drug makers Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay in a product-liability case to $38.1 million from the more than $9 billion awarded by a jury earlier this year.

Flu-Shot Supply Dented by Production Woes

online.wsj.com — Some influenza-vaccine makers have delayed shipments to U.S. doctors and pharmacies because of production problems, forcing some health-care providers to put off vaccinations as flu season gets under way. The U.S. Centers for Disease Control and Prevention says there have been delays in shipments-from big manufacturers including GlaxoSmithKline PLC and Sanofi SA-that were originally anticipated for August and September.

Study to Look at Blood Products From Ebola Survivors as Treatment

online.wsj.com — Researchers plan to test the effectiveness of transfusing blood products from Ebola survivors into infected patients, as a potential near-term countermeasure to the outbreak in West Africa.

Johnson & Johnson to Begin Testing Ebola Vaccine in January

online.wsj.com — Johnson & Johnson said it would begin testing an Ebola-virus vaccine in humans in January and could have 250,000 doses available in May, if health authorities deem it safe and promising enough to distribute more broadly. There is no approved vaccine guarding against the deadly Ebola virus.

Eli Lilly CEO Lechleiter Sees Light After a Difficult Year

online.wsj.com — Eli Lilly & Co. is deep into what Chief Executive John C. Lechleiter calls the "toughest year" in the drug maker's 138-year history. Revenue at Lilly has plunged because of generic competition that followed patent expirations for several of its top-selling drugs, including the antidepressant Cymbalta.

Better Late Than Never: CMS Improves The Doctor Payment Website

blogs.wsj.com — Late Friday, the Centers for Medicare and Medicaid services issued a so-called beta release of an online search tool on its Open Payments website. The tool lets you search by a physician's name, location or specialty, as well as by the names of teaching hospital and companies.

Ebola Drug Race Ramps Up in Earnest

online.wsj.com — When it started developing an Ebola drug in 2010, Tekmira Pharmaceuticals Corp. wasn't counting on finding infected humans to test it in. Instead, the company planned to seek approval based on animal studies, which regulators sometimes allow.

Gates Foundation Asks CSL to Explore Plasma Treatment for Ebola

online.wsj.com — CSL Ltd., an Australian maker of blood-plasma therapeutics, says it is exploring whether it can develop a plasma product to treat Ebola. Chief Executive Paul Perreault said he formed a small team to assess the feasibility at the request of the Bill & Melinda Gates Foundation a few weeks ago.
More Articles →
Oct 31, 2014

RT @stefaniei: The debate over how to ethically and effectively conduct Ebola drug trials. Should some patients get placebo? on.wsj.com/1tWFrFN

Oct 30, 2014

RT @AP: MORE: Man wanted in trooper ambush was captured by U.S. marshals in an abandoned airplane hangar, officials say: apne.ws/1yKzuuC

Oct 29, 2014

Great behind-the-scenes look at insider-trading probe stemming from Medicare review of Dendreon drug: on.wsj.com/1ryjzcW via @WSJ $DNDN

Oct 23, 2014

Researchers plan to test transfusing blood products from Ebola survivors into infected patients on.wsj.com/1tgdgkQ via @WSJ

Oct 23, 2014

RT @ArmstrongDrew: Not even Ebola is immune from the reach of Washington's K Street lobbyists. bloomberg.com/politics/artic…

Oct 22, 2014

US companies get 9% of foreign profits via tax haven Luxembourg, but only 0.1% of foreign workforce there: on.wsj.com/ZN6Xsb via @WSJ

Oct 20, 2014

RT @jonathanrockoff: $LLY CEO Lechleiter: U.S. corp taxes need changing "but we see v. little impetus right now coming out of Washington." on.wsj.com/1wi99Cv

Oct 20, 2014

Fujifilm to boost production of Antiflu drug for Ebola treatment on.wsj.com/1wjNw4W via @WSJ

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.

Share This Profile